A Multicentre Double-Blinded Randomized Head-to-Head Study.

Trial Profile

A Multicentre Double-Blinded Randomized Head-to-Head Study.

Phase of Trial: Phase III

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Olanzapine (Primary) ; Sertindole (Primary)
  • Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms SEROLA
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 01 Nov 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 19 Dec 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top